기업 프로필 · Healthcare

Straumann Holding AG

STMN · SW
거래소
SW
국가 / 지역
Switzerland
직원 수
11,319
웹사이트
www.straumann.com
현재가
106.8
2026년 6월 27일 종가
적정 매수가
76
안전마진 진입가
베일리 성장 점수
53/100
보통
내재가치 · 3단계 구간 현재가 106.8 · 적정 내재가치 구간 내

종합 밸류에이션 구간 · 보수적 70–76 / 적정 85–129 / 낙관적 134–145. 106.8 기준, 적정 내재가치 구간 내.

2026년 6월 17일 Earnings Needs review

Straumann raised 2026 profitability outlook

Straumann raised its 2026 core EBIT margin expansion outlook, citing lower-than-expected tariffs and faster efficiency gains.

Possible impact:May affect expectations for full-year profitability and earnings upgrades.

The Wall Street JournalView source

Automatically summarized from public sources; for context only, not investment advice.

시가총액CHF 164.95억
매출 (TTM)CHF 26.05억
EBITDACHF 7.51억
순이익률13.66%
ROE17.01%
PER (TTM)46.39
선행 PER32.79
PEG1.58
EPSCHF 2.23
배당수익률0.95%
52주 범위CHF 72.22 – CHF 110.27

데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

연혁

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

업계 내 위치

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

이 종목에 대한 리포트가 아직 해당 언어로 없습니다.